Johnson & Johnson · News · TradingHolo

Johnson & Johnson · News · TradingHolo

JNJ news

Headlines tagged to this company

Johnson & Johnson (JNJ) Posts Q3 Results, Raises 2026 Guidance

TradingView · 7 d ago

Johnson & Johnson 3Q Adj EPS $2.59 >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson 3Q EPS 9c >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson 3Q International Sales $10.44B >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson 3Q Net $210M >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson 3Q Worldwide Innovative Medicine Sales $16.76B >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson 3Q Worldwide MedTech Sales $8.64B >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson Now Sees 2026 Adjusted Operational EPS $10.95-$11.05 Vs Prior View $10.86-$11.01 >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson Raises 2026 View To Adj EPS $11.05-Adj EPS $11.15 Vs Prior View $10.96-$11.11 >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson reports Q3 2026 results, raises 2026 guidance

BusinessWire · 7 d ago

Johnson & Johnson: 3Q Innovative Medicine Operational Sales Growth Partially Offset by Impact From Stelara, Simponi/Simponi Aria, Remicade, Opsumit/Opsynvi and Imbruvica >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson: In 3Q, Advanced Breakthroughs That Will Redefine Care for Patients, From Delivering One of Our Most Transformative MedTech Innovations With Ottava to Reporting Positive Phase 3 Results in Multiple Myeloma >JNJ

Dow Jones Newswires · 7 d ago

Johnson & Johnson: Latest 3Q Reflects One-Time Special Charge for Proposed Talc Litigation Resolution, Acquisition of Firefly Bio and Strategic Collaboration With Sail Biomedicines >JNJ

Dow Jones Newswires · 7 d ago

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones Newswires · 7 d ago

New Tremfya® Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups

Reuters · 7 d ago

J&J long-term Tremfya data demonstrates Crohn's remission through three years

Seeking Alpha · 7 d ago

Johnson & Johnson earnings on deck: What to expect

Seeking Alpha · 8 d ago

JNJ Q3'26 Earnings: EPS estimate is 2.52 USD

TradingView · 8 d ago

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

Stocktwits · 8 d ago

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

Stocktwits · 9 d ago

← Previous More news →